Retinal Vein Occlusion: Risk Factors and What Injections Can Do

What Is Retinal Vein Occlusion?

Retinal vein occlusion (RVO) happens when a vein in the retina gets blocked. The retina is the light-sensitive layer at the back of your eye. When blood can’t flow out properly, fluid leaks into the retina, causing swelling - especially in the macula, the part responsible for sharp central vision. This leads to sudden, painless vision loss. It can be mild, like blurry spots, or severe, where you can barely make out shapes.

There are two main types: central retinal vein occlusion (CRVO), which blocks the main vein, and branch retinal vein occlusion (BRVO), which affects smaller branches. BRVO is more common and often happens where a hard artery presses down on a vein, like a kinked hose. CRVO tends to be more serious and affects vision more broadly.

It’s not rare. About 16 million people worldwide have RVO. Most cases happen after age 55, but it can strike younger people too - especially those with blood disorders or who take birth control pills. The blockage isn’t a clot like in a heart attack. It’s more about slow, clogged flow, damaged vessel walls, and thickened blood - the same trio of problems doctors call Virchow’s triad.

Who’s Most at Risk?

Age is the biggest risk factor. Over 90% of CRVO cases happen in people over 55. Half of all RVO cases are in those 65 or older. But don’t think you’re safe just because you’re young. About 5 to 10% of cases occur in people under 45.

High blood pressure is the most common link. Up to 73% of CRVO patients over 50 have it. Even in younger patients, uncontrolled hypertension doubles the risk. Diabetes is another major player - about 10% of RVO patients have it, and their vision tends to recover slower.

Cholesterol matters too. If your total cholesterol is above 6.5 mmol/L, your risk jumps. About 35% of RVO patients fall into this category, no matter their age. Glaucoma also increases risk, especially if pressure inside the eye is high and the blockage is near the optic nerve.

Lifestyle habits play a role. Smoking is found in 25-30% of cases. Being overweight or inactive adds to the problem by worsening blood flow and increasing inflammation. In younger women under 45, oral contraceptives are the most common trigger for CRVO. That’s why doctors ask about birth control when someone young comes in with sudden vision loss.

Less common but serious: blood disorders. Polycythemia vera, multiple myeloma, leukemia, or inherited clotting problems like factor V Leiden can cause RVO in younger patients. These aren’t everyday causes, but if you’re under 45 and get RVO without other risk factors, your doctor should test for them.

How Are Injections Used to Treat RVO?

Injections don’t fix the blocked vein. They treat the side effects - mainly macular edema, the swelling that ruins your vision. The two main types of injections are anti-VEGF drugs and steroids.

Anti-VEGF injections - like ranibizumab (Lucentis), aflibercept (Eylea), and bevacizumab (Avastin) - block a protein called vascular endothelial growth factor. This protein causes leaky blood vessels and swelling. Studies show these drugs can improve vision by 15-18 letters on an eye chart within 6 months. That’s like going from reading only the top line to reading most of the chart.

Steroid injections, like Ozurdex (dexamethasone implant), work differently. They reduce inflammation and swelling over a longer period. One study found 28% of CRVO patients gained 15 or more letters of vision with Ozurdex, compared to 13% with a placebo. But steroids come with risks: cataracts develop in 60-70% of patients who still have their natural lens, and eye pressure can spike, requiring extra medication.

Doctors usually start with anti-VEGF. It’s safer long-term. Steroids are saved for people who don’t respond well or can’t handle frequent shots.

What’s the Treatment Process Like?

First, your eye doctor confirms RVO with tests. They’ll check your vision, look at the back of your eye with a special lens, and do an OCT scan - a non-invasive imaging test that shows swelling in the retina. A fluorescein angiogram, where dye is injected into your arm and photos are taken of your retina, helps map the blocked veins.

If swelling is present - usually when the central retinal thickness is over 300 micrometers - injections begin. Most patients get shots every 4 weeks at first. After a few months, if the swelling improves, the gap between shots can stretch to 6 or 8 weeks. Some doctors use a “treat-and-extend” plan: keep treating until the eye is dry, then slowly increase the time between visits.

The injection itself takes 5 to 7 minutes. Your eye is numbed with drops, cleaned with antiseptic, and held open with a tiny clamp. The needle goes through the white part of the eye. You might feel pressure, but not pain. Afterward, you might see floaters or have a red spot on the white of your eye - that’s normal and fades in a few days.

Complications are rare. About 1 in 5,000 injections leads to a serious infection called endophthalmitis. More common: a small bleed under the eye’s surface (25-30% of cases), temporary pressure spike (15-20%), or seeing floaters (10%).

Real Patient Experiences

People’s stories vary. One man in his 60s started monthly Lucentis shots after CRVO. After four months, his vision went from 20/200 to 20/60 - enough to drive again. But each injection cost him $150 out of pocket. On a fixed income, that added up fast.

Another patient tried eight Avastin shots with almost no improvement. Then she got the Ozurdex implant. Within weeks, her vision jumped 10 lines on the chart. She paid $2,500 out of pocket, but it was worth it.

But not everyone has success. Some people feel anxious before every injection. One Reddit user said the fear was worse than the shot itself - even though the clinic does 50 a day and it’s routine. Others get tired of the schedule. One woman missed appointments after 18 months because the stress became too much, even though her vision kept improving.

Surveys show 78% of RVO patients see better after a year of anti-VEGF treatment. But 63% say cost is a burden, and 41% feel burned out from the frequent visits.

Costs and Access

Anti-VEGF drugs are expensive. Lucentis and Eylea cost around $2,000 per shot in the U.S. Avastin, which is the same drug used for cancer, costs about $50. It’s not officially approved for eye use, but doctors use it off-label because it works just as well.

In safety-net hospitals, 60-70% of RVO injections are Avastin. In private clinics, it’s only 25-30%. That gap reflects income inequality in care. Many patients can’t afford the branded versions, even with insurance.

There’s hope on the horizon. New delivery systems, like the Susvimo implant, are being tested for RVO. It’s a tiny device placed in the eye that slowly releases ranibizumab for months, cutting injections from monthly to quarterly. It’s already approved for another eye disease and could change the game.

What’s Next in Treatment?

Doctors are moving away from “one-size-fits-all” monthly shots. New studies show treat-and-extend plans work just as well with fewer visits. One 2023 study found patients needed 30% fewer injections with this method.

Gene therapy is coming. RGX-314, a one-time injection that makes your eye produce its own anti-VEGF, is in trials. If it works, you might only need one shot instead of dozens.

Another new drug, OPT-302, blocks a different part of the VEGF system. It’s being tested with Eylea for patients whose swelling won’t go away with standard treatment.

Doctors are also using new imaging tools - like OCT angiography - to predict who will respond best to which treatment. It’s not science fiction anymore. Personalized treatment is here.

What Should You Do If You’re Diagnosed?

First, control your risk factors. Lower your blood pressure. Manage your blood sugar. Quit smoking. Get moving. These steps won’t undo the blockage, but they prevent more damage.

Stick with treatment. Vision can improve, but only if you keep up with injections. Missing appointments can mean permanent vision loss.

Ask about costs. Talk to your doctor about Avastin if you’re struggling with bills. Many clinics offer financial aid or payment plans.

Find support. Online communities like the American Macular Degeneration Foundation forum help people cope with anxiety, fatigue, and fear. You’re not alone.

Final Thoughts

Retinal vein occlusion is serious, but it’s not a death sentence. Vision can be saved - even restored - with timely treatment. The injections aren’t perfect. They’re frequent, costly, and sometimes stressful. But they work. And the future is getting better.

Doctors are learning how to tailor treatment to each person. The goal isn’t just to slow vision loss - it’s to give you back your life. One injection at a time.